You are here: Industry Insights > acquisition

News List

Therapix Biosciences Terminates FSD Acquisition Letter of Intent americanpharmaceuticalreview
December 24, 2018
Therapix Biosciences, a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments.....
Novartis makes offer to acquire French CDMO CellforCure pharmaceutical-technology
December 24, 2018
Novartis has made an offer to acquire CellforCure, a France-based contract development and manufacturing organisation (CDMO) producing cell and gene therapies in Europe, from LFB for an undisclosed amount.....
Astellas Pharma, Taisho Pharmaceuticals, AMAG Pharmaceuticals pharmaceutical-technology
December 24, 2018
Astellas Pharma has completed the acquisition of Potenza Therapeutics for $405m.Astellas made an upfront payment of $164.6m and has agreed to...
BMS confirms Taisho’s $1.6bn offer for UPSA pharmaphorum
December 21, 2018
After protracted speculation, Bristol-Myers Squibb has confirmed it plans to divest its French over-the-counter (OTC) medicines business UPSA to Japan’s Taisho Pharma in a $1.6 billion deal.
Japan’s Taisho offers to acquire Bristol-Myer’s UPSA for $1.6bn pharmaceutical-technology
December 21, 2018
Japan-based Taisho Pharmaceutical has offered to acquire US-based Bristol-Myers Squibb’s UPSA consumer health business for $1.6bn.....
Alcon Announces Acquisition of Tear Film Innovations americanpharmaceuticalreview
December 20, 2018
Alcon has acquired Tear Film Innovations, a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye.....
Croda Acquires Vaccine Adjuvant Specialist Brenntag Biosector americanpharmaceuticalreview
December 19, 2018
Croda has signed a definitive agreement with Brenntag Nordic A/S to acquire Brenntag Biosector, for a total consideration of €72 million in cash....
Grünenthal buys certain rights to AZ’s Nexium and Vimovo for $922m pharmaphorum
December 18, 2018
AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million.
Merck to buy animal health firm Antelliq for $2.4bn pharmaphorum
December 18, 2018
Merck & Co is to buy animal health firm Antelliq Group for $2.4 billion in a bid to bolster this fast-growing business unit.Antelliq, which is majority owned by private investors BC Partners....
Astellas buys Potenza Therapeutics for up to $405m pharmaceutical-technology
December 18, 2018
Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405m.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page